To include your compound in the COVID-19 Resource Center, submit it here.

Cullinan raises $150M in series A

On Oct. 3, Cullinan Oncology LLC (Cambridge, Mass.) raised $150 million in a series A round led by the UBS Oncology Impact Fund

Read the full 238 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE